Bioavailability of Tebipenem (SPR994) Crushed Tablet

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to measure the amount of the antibiotic, tebipenem (SPR994) that is bioavailable after crushing the tablet and administering through a feeding tube with and without tube feeds.
Epistemonikos ID: 9b1f9fac5046e1776693b45785e2acf15c00a6fc
First added on: May 10, 2024